Navigation Links
Prostate cancer treatment overused in some older patients
Date:2/27/2012

Treatment is not always warranted for older men with prostate cancer and a short life expectancy, Yale School of Medicine researchers report in the Feb. 27 Archives of Internal Medicine.

"Treatment can do more harm than good in some instances," said senior author on the study Cary Gross, M.D., associate professor of internal medicine at Yale School of Medicine. "Among men who are older and have less aggressive forms of prostate cancer, their cancer is unlikely to progress or cause them harm in their remaining years."

Gross and his team analyzed nine years of Medicare data and found that over the past decade, there has been a trend towards higher use of curative treatment for prostate cancer among men with certain types of tumors and a short life expectancy. The study included 39,270 patients between the ages of 67 and older.

These results suggest that cancer treatment was increasingly aggressive in patients who had the lowest likelihood of seeing clinical benefits, Gross said, noting that while not treating potentially fatal cancer can reflect poor-quality care, aggressively managing disease that is unlikely to progress puts patients at risk for complications and increases costs without medical benefits.

"We found that the percentage of men who received treatment for their prostate cancer treatments increased over time from 61.2% to 67.6% from 1998 through 2007," said Gross, who is a member of Yale Cancer Center. "However, we were surprised to find that the biggest increase was among men with moderate-risk prostate cancer who had the shortest life expectancy. On the other hand, cancer treatment decreased among men with low-risk tumors and longer life expectancy."

Treating patients with shorter life expectancy may add costs or complications without contributing to quality of life, he said. The National Comprehensive Cancer Network practice guidelines in oncology recommend actively monitoring patients as an alternative to medication for patients with less aggressive tumor types and shorter life expectancies.

Gross said that the use of cancer therapies should be guided by clinical evidence and patient preferences. "Future work should explore how better to incorporate both cancer characteristics and patient life expectancy into decision making," said Gross.


'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert

Related medicine news :

1. Telomere failure, telomerase activation drive prostate cancer progression
2. Nerve-Sparing Prostate Surgery Helps Men Retain Sexual Function
3. New method makes it easier to treat prostate and pancreatic cancer
4. Curry spice component may help slow prostate tumor growth
5. Heart disease may be a risk factor for prostate cancer
6. A new screening method for prostate cancer
7. Investigational urine test can predict high-risk prostate cancer in men who chose watchful waiting
8. Vigorous exercise linked to gene activity in prostate
9. Prostate cancer risk halved for subfertile men
10. Science Shows How Exercise Might Help in Prostate Cancer
11. Study Compares 3 Common Prostate Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2016)... Aliso Viejo, CA (PRWEB) , ... May 01, 2016 , ... ProBrand Reveal Volume 2 ... Pro X . With ProBrand Reveal Volume 2 keyframeless animations, users can easily create a ... over the look and feel of the various presets. Use these title presets to add ...
(Date:5/1/2016)... CA (PRWEB) , ... May 01, 2016 , ... Good ... those in need of chiropractic help. The agency offers a verity of health, life ... chiropractic need. According to Chris Nelson at the firm, “Many insurance plans don’t cover ...
(Date:4/30/2016)... , ... April 30, 2016 , ... ... Studios. With inMotion3D Abstract users can distort and manipulate three-dimensional shapes with ease ... rotation, columns, rows, ranks, point, lines, polygons, polygon texture animation, opacity texture animation, ...
(Date:4/30/2016)... (PRWEB) , ... April 30, 2016 , ... ... today announced RANKED Health , a program to critically evaluate and rank ... goal of the program is to provide independent, unbiased and accurate information to ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... President and CEO of EMED, today signed a multifaceted agreement which will allow ... the Northern Caribbean University Department of Natural and Applied Sciences, Allied Health and ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016  While Abbott,s announced purchase of St. ... repair and stent business, healthcare research firm Kalorama ... firmly into patient monitoring.  Kalorama said that patient ... areas, with double-digit growth expected the next 5 ... Remote Patient Monitoring . Abbott Laboratories agreed ...
(Date:4/28/2016)... April 28, 2016  The blood testing market in ... according to Kalorama Information and The Freedonia Group in ... nucleic acid testing.  The healthcare research firm said that ... developing blood collection stations and in improving testing at ... Information,s report, Blood Testing Market in China ...
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
Breaking Medicine Technology: